Oral vs Injectable Semaglutide: A Daily Routine or a Weekly One
Oral and injectable semaglutide are the same molecule taken two ways: a capsule every day, or an injection under the skin once a week. The difference is routine and absorption. By mouth, less of the drug reaches you and the amount varies more from person to person, so the daily habit matters more; the weekly injection is the more predictable delivery. At ACT 2 both routes cost the same per month.
This page compares the two routes. The branded oral products, Rybelsus and the Wegovy pill, are compared in detail on oral semaglutide vs Rybelsus and the Wegovy pill.
Oral and injectable semaglutide side by side
| Oral semaglutide | Injectable semaglutide | |
|---|---|---|
| What it is | Semaglutide, a GLP-1 receptor agonist, taken by mouth | The same molecule, injected under the skin |
| How it is taken at ACT 2 | A daily capsule, as directed by your clinician | A once-weekly injection, with the regimen guided by your clinician |
| How much reaches you | Lower and more variable, and more sensitive to routine | More predictable |
| Branded FDA-approved versions | Rybelsus (type 2 diabetes); Wegovy tablets (weight management) | Ozempic (type 2 diabetes); Wegovy injection (weight management) |
| What ACT 2 prescribes | Compounded capsule, not FDA-approved | Compounded injection, not FDA-approved |
| What is monitored | As for the injection, plus attention to other daily tablets such as thyroid medication | Digestive side effects and the warnings on the branded labels |
| Who it tends to suit | People who want to avoid injections and can keep a daily rhythm | People who prefer a weekly routine and the more predictable delivery |
| Price at ACT 2 | $299 a month | $299 a month, or less on a package |
A daily capsule or a weekly injection
Semaglutide is a peptide, and the digestive system is built to break peptides down. Getting it through the stomach intact is the hard part of an oral version, which is why oral absorption is lower and more sensitive to routine than injection. The injection avoids the gut entirely.
That shapes the routine. The capsule is a daily habit, and how consistently it is taken affects how much reaches you. The injection is one appointment with yourself a week. People who travel, work shifts or find a strict morning routine impossible often do better with weekly. People for whom a needle is the barrier, and who can keep a daily habit, may prefer the capsule. The oral semaglutide page covers that trade-off in more depth.
What the branded labels require
The administration rules below come from the FDA-approved labels of branded products. They describe those products. Your clinician's instructions govern the compounded capsule or injection you are prescribed.
Rybelsus. Its label says to take one tablet once daily, on an empty stomach in the morning, with a small amount of plain water and no other liquid. The tablet is swallowed whole, never split, crushed or chewed, and the label sets a waiting period afterward before eating, drinking anything else or taking other oral medicines.
Wegovy tablets. The Wegovy label gives the same morning rules for its tablets: once daily on an empty stomach with a small amount of water only, swallowed whole, then the same wait before food, drink or other oral medicines.
Wegovy injection. The Wegovy label says to inject once weekly on the same day each week, at any time of day, with or without meals, under the skin of the abdomen, thigh or upper arm.
Put side by side, the labels show the real difference between routes: the tablets ask for a strict routine every morning, the injection asks for one fixed day a week. The dose is raised gradually on both, and the Wegovy label explains that the stepwise start is to reduce the risk of digestive side effects.
What is monitored on each
The molecule is the same, so the main warnings are shared. The Wegovy label, which covers both its injection and its tablets, carries a boxed warning about thyroid C-cell tumors seen in rodents, a contraindication for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, and warnings about pancreatitis and gallbladder disease. Digestive side effects are the commonest problem by either route.
The oral route adds one consideration. Semaglutide slows stomach emptying, which can change how other tablets are absorbed, and the Rybelsus label reports that levothyroxine exposure rose when it was taken with semaglutide tablets. Anyone on thyroid medication should read oral semaglutide and thyroid medication. Because oral absorption varies more, early feedback on how you are responding matters more on the capsule.
At ACT 2 care starts from a baseline lab panel and continues with clinical review. The GLP-1 side effects FAQ covers what to expect.
Regulatory status
Branded semaglutide is FDA-approved by both routes: Ozempic injection and Rybelsus tablets for type 2 diabetes, and Wegovy injection and Wegovy tablets for weight management. The Wegovy label sets separate dosing schedules for its injection and its tablets, so oral and injected semaglutide are not dosed alike.
The oral and injectable semaglutide prescribed through ACT 2 are compounded by a licensed pharmacy. They are not FDA-approved, and they are not equivalent to or interchangeable with Rybelsus, Wegovy or Ozempic. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. The compounded semaglutide vs Wegovy page explains what that means for the injection, and the Rybelsus and Wegovy pill page for the capsule.
Who each tends to suit
The capsule tends to suit adults who want a GLP-1 approach without injections and can keep a daily rhythm. The injection tends to suit adults who want the more predictable delivery and a weekly rather than daily routine. In practice, the route you will keep using consistently usually matters more than the route on paper, and switching between them is a clinical decision made on your response and preference.
Price at ACT 2
The two routes cost the same: oral semaglutide is $299 a month and the semaglutide injection is $299 a month. The difference is in packages. The capsule is sold monthly only, while the injection also comes as a 3-month package ($799) or a 6-month package ($1,549), which brings it to $258 a month. Lab work is priced separately. The semaglutide cost page covers yearly totals and insurance.
When neither is the answer
If a daily routine is hard and needles are a firm no, the choice may need widening rather than narrowing: tirzepatide is another option to discuss, and orforglipron is an oral GLP-1 with a different routine. A personal or family history of medullary thyroid carcinoma or MEN 2 rules out semaglutide by any route. And where insulin resistance rather than weight is the main problem, metformin may be the conversation.
Frequently asked questions
Both contain semaglutide, a GLP-1 receptor agonist. The oral form is a daily capsule or tablet; the injectable form is a once-weekly injection under the skin. By mouth, less of the drug is absorbed and the amount varies more between people, so routine matters more. The injection is the more predictable delivery. At ACT 2 both are compounded and cost the same per month.
Both routes deliver semaglutide, but oral absorption is lower and more variable, so the injection is the more predictable delivery. Branded trial results belong to the specific FDA-approved products they were run on, and ACT 2 publishes no comparative outcome figures for compounded medications. The route you will take consistently often matters more. Your clinician helps you choose and monitors your response.
At ACT 2 the compounded capsule is taken daily as your clinician directs. For the branded tablets, the Rybelsus and Wegovy labels say to take them once daily on an empty stomach in the morning with a small amount of plain water, swallow them whole, and wait the labeled interval before eating, drinking or taking other oral medicines.
Yes. Oral semaglutide is $299 a month and the semaglutide injection is $299 a month. The injection is also sold as 3- and 6-month packages, which lower its monthly figure to as little as $258; the capsule is monthly only. Lab work is priced separately in both cases.
Yes, switching routes is a clinical decision made with your clinician based on your response and preference, and it is not unusual. Oral and injected semaglutide are not dosed alike; the Wegovy label sets separate dosing schedules for its injection and its tablets. Do not convert doses yourself. Your clinician sets the regimen for the new route.
It can. Semaglutide slows stomach emptying, which can change how other tablets are absorbed, and the Rybelsus label reports that levothyroxine exposure increased when it was taken with semaglutide tablets. If you take thyroid medication, tell your clinician before starting, because your thyroid levels may need checking. ACT 2's page on oral semaglutide and thyroid medication covers this in detail.
Where this fits in your plan
Decide first whether semaglutide is right for you at all; that is a clinical question about history, labs and the warnings above. Then choose the route by your life rather than the label: the one you will take reliably, week after week or morning after morning.
Related: Oral semaglutide · Semaglutide injection · Oral semaglutide evidence · Semaglutide vs tirzepatide · Semaglutide cost · Weight loss FAQ
We measure first. Then we act.
References
- Novo Nordisk. RYBELSUS (semaglutide) tablets: prescribing information. https://www.novo-pi.com/rybelsus.pdf
- Novo Nordisk. WEGOVY (semaglutide) injection and tablets: prescribing information. https://www.novo-pi.com/wegovy.pdf
- Novo Nordisk. OZEMPIC (semaglutide) injection: prescribing information. https://www.novo-pi.com/ozempic.pdf
- MedlinePlus. Semaglutide injection. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a618008.html
- U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
Prices shown are current catalog prices and are confirmed at your eligibility review.